We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · June 26, 2022

Combination vs Standard Therapy Using Metformin for Patients With Untreated Type 2 Diabetes

Diabetes Research and Clinical Practice


Additional Info

Diabetes Research and Clinical Practice
Metformin plus a low hypoglycemic risk antidiabetic drug vs. metformin monotherapy for untreated type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
Diabetes Res. Clin. Pract. 2022 Jun 01;189(2022)109937, WT Hung, YJ Chen, CY Cheng, B Ovbiagele, M Lee, CY Hsu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading